Abstract
Background The mechanism of epileptogenesis is not well established. There is higher incidence of seizures among patients with chronic inflammatory disease. Cytokines are rapidly induced in the brain after a variety of stimuli including inflammation. Aim of this study was to produce various inflammatory models and seizure to understand the role of TNFα in above mentioned models. Materials and methods A total of 54 male rats were included in the study. Animals were divided into 3 groups of colitis, arthritis, and cotton wool granuloma. Each group had 3 subgroups of control, model and treatment. At the end of 3 days in colitis, 17 days in arthritis and 7 days in cotton wool granuloma groups a subconvulsive dose of PTZ (40 mg/kg i.p) was injected to note seizure onset and seizure score. Brain samples were subjected to DNA fragmentation testing. Presence of inflammation was confirmed by morphology and histology. Plasma and brain TNFα levels were measured. Results The models of colitis, arthritis and CWG were effectively produced as evidenced by morphology and histology scores ( p < 0.001). Seizure onset was reduced and grade was increased ( p < 0.001). Thalidomide reduced the morphological, histological ( p < 0.002), DNA fragmentation and seizure grade ( p < 0.001) while increased seizure onset ( p < 0.001) in the arthritis group. TNFα levels in both plasma and brain were reduced following thalidomide treatment ( p < 0.002) in arthritis group. There were no significant findings in colitis or cotton wool granuloma groups. Conclusion Inflammation was associated with decreased threshold to PTZ induced seizure. Thalidomide is effective in reducing the extent of arthritis as well as reducing the seizure scoring and increasing seizure onset in the adjuvant arthritis group. Thalidomide was also effective in reducing TNFα levels thus contributing to its antiepileptic activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.